212 related articles for article (PubMed ID: 10405788)
1. Hypertension and insulin resistance: role of peroxisome proliferator-activated receptor gamma.
Itoh H; Doi K; Tanaka T; Fukunaga Y; Hosoda K; Inoue G; Nishimura H; Yoshimasa Y; Yamori Y; Nakao K
Clin Exp Pharmacol Physiol; 1999 Jul; 26(7):558-60. PubMed ID: 10405788
[TBL] [Abstract][Full Text] [Related]
2. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
Fukunaga Y; Itoh H; Doi K; Tanaka T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Hosoda K; Kook H; Ueda M; Nakao K
Atherosclerosis; 2001 Sep; 158(1):113-9. PubMed ID: 11500181
[TBL] [Abstract][Full Text] [Related]
3. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
Murakami K; Tobe K; Ide T; Mochizuki T; Ohashi M; Akanuma Y; Yazaki Y; Kadowaki T
Diabetes; 1998 Dec; 47(12):1841-7. PubMed ID: 9836514
[TBL] [Abstract][Full Text] [Related]
4. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
Albrektsen T; Frederiksen KS; Holmes WE; Boel E; Taylor K; Fleckner J
Diabetes; 2002 Apr; 51(4):1042-51. PubMed ID: 11916924
[TBL] [Abstract][Full Text] [Related]
5. Thiazolidinediones--tools for the research of metabolic syndrome X.
Komers R; Vrána A
Physiol Res; 1998; 47(4):215-25. PubMed ID: 9803467
[TBL] [Abstract][Full Text] [Related]
6. [Mechanisms of action of thiazolidinediones].
Girard J
Diabetes Metab; 2001 Apr; 27(2 Pt 2):271-8. PubMed ID: 11452221
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
Vidal-Puig AJ; Considine RV; Jimenez-Liñan M; Werman A; Pories WJ; Caro JF; Flier JS
J Clin Invest; 1997 May; 99(10):2416-22. PubMed ID: 9153284
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats.
Diep QN; Schiffrin EL
Hypertension; 2001 Aug; 38(2):249-54. PubMed ID: 11509485
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients.
Auboeuf D; Rieusset J; Fajas L; Vallier P; Frering V; Riou JP; Staels B; Auwerx J; Laville M; Vidal H
Diabetes; 1997 Aug; 46(8):1319-27. PubMed ID: 9231657
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
[TBL] [Abstract][Full Text] [Related]
12. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
Vidal-Puig A; Jimenez-Liñan M; Lowell BB; Hamann A; Hu E; Spiegelman B; Flier JS; Moller DE
J Clin Invest; 1996 Jun; 97(11):2553-61. PubMed ID: 8647948
[TBL] [Abstract][Full Text] [Related]
13. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
Rieusset J; Touri F; Michalik L; Escher P; Desvergne B; Niesor E; Wahli W
Mol Endocrinol; 2002 Nov; 16(11):2628-44. PubMed ID: 12403851
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists.
Gerhold DL; Liu F; Jiang G; Li Z; Xu J; Lu M; Sachs JR; Bagchi A; Fridman A; Holder DJ; Doebber TW; Berger J; Elbrecht A; Moller DE; Zhang BB
Endocrinology; 2002 Jun; 143(6):2106-18. PubMed ID: 12021175
[TBL] [Abstract][Full Text] [Related]
15. Novel insulin sensitizers: pharmacogenomic aspects.
Otto C; Lehrke M; Göke B
Pharmacogenomics; 2002 Jan; 3(1):99-116. PubMed ID: 11966407
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and additional vascular effects of thiazolidinediones.
Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ
Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315
[TBL] [Abstract][Full Text] [Related]
17. A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice.
Fukui Y; Masui S; Osada S; Umesono K; Motojima K
Diabetes; 2000 May; 49(5):759-67. PubMed ID: 10905484
[TBL] [Abstract][Full Text] [Related]
18. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes.
Tamori Y; Masugi J; Nishino N; Kasuga M
Diabetes; 2002 Jul; 51(7):2045-55. PubMed ID: 12086932
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte membrane phospholipids and PPAR-gamma expression in obese women: relationship to hyperinsulinemia.
Zeghari N; Vidal H; Younsi M; Ziegler O; Drouin P; Donner M
Am J Physiol Endocrinol Metab; 2000 Oct; 279(4):E736-43. PubMed ID: 11001753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
